ArticleJournal of cancer research and clinical oncology2014

The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer.

Jingya Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.